Twirla® (levonorgestrel/ethinyl estradiol) – New drug approval
February 14, 2020 - Agile Therapeutics’ announced the FDA approval of Twirla (levonorgestrel/ethinyl estradiol), as a method of contraception for use in women of reproductive potential with a body mass index (BMI) < 30 kg/m2 for whom a combined hormonal contraceptive is appropriate.
Top